Form 3601 Medical Device User Fee Cover Sheet

Medical Device User Fee Cover Sheet - FDA Form 3601

0511_Form 3601

Medical Device User Fee Cover Sheet

OMB: 0910-0511

Document [pdf]
Download: pdf | pdf
  Site: MDUFMA Cover Sheet
 
 
 

Page 1 of 2

 
Form Approved: OMB No. 0910-0511 Expiration Date: August 31, 2019. See Instructions for OMB Statement.
 

DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
MEDICAL DEVICE USER FEE COVER SHEET

PAYMENT IDENTIFICATION NUMBER: MD
Write the Payment Identification number on your check.

A completed cover sheet must accompany each original application or supplement subject to fees. If payment is sent by U.S. mail or
courier, please include a copy of this completed form with payment. Payment and mailing instructions can be found at:
http://www.fda.gov/oc/mdufma/coversheet.html
1. COMPANY NAME AND ADDRESS (include name, street
address, city state, country, and post office code)
 

 
 
 
 

2. CONTACT NAME
 

 
2.1 E-MAIL ADDRESS
 

 
2.2 TELEPHONE NUMBER (include Area code)
1.1 EMPLOYER IDENTIFICATION NUMBER (EIN)

 

 
2.3 FACSIMILE (FAX) NUMBER (Include Area code)

3. TYPE OF PREMARKET APPLICATION (Select one of the following in each column; if you are unsure, please refer to the application
descriptions at the following web site:
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm345263.htm
Select an application type:
[ ] Premarket notification(510(k)); except for third party
[ ] 513(g) Request for Information

3.1 Select a center
[ ] CDRH
[ ] CBER

[ ] Biologics License Application (BLA)
[ ] Premarket Approval Application (PMA)
[ ] Modular PMA
[ ] Product Development Protocol (PDP)
[ ] Premarket Report (PMR)

3.2 Select one of the types below
[ ] Original Application
Supplement Types:
[ ] Efficacy (BLA)
[ ] Panel Track (PMA, PMR, PDP)

[ ] 30-Day Notice
[ ] De Novo Request

[ ] Real-Time (PMA, PMR, PDP)
[ ] 180-day (PMA, PMR, PDP)

4. ARE YOU A SMALL BUSINESS? (See the instructions for more information on determining this status)
[ ] YES, I meet the small business criteria and have submitted the required
qualifying documents to FDA
4.1 If Yes, please enter your Small Business Decision Number:

[ ] NO, I am not a small business

5. FDA WILL NOT ACCEPT YOUR SUBMISSION IF YOUR COMPANY HAS NOT PAID AN ESTABLISHMENT REGISTRATION FEE THAT IS
DUE TO FDA. HAS YOUR COMPANY PAID ALL ESTABLISHMENT REGISTRATION FEES THAT ARE DUE TO FDA?
[ ] YES (All of your establishments have registered and paid the fee, or this is your first device and you will register and pay the fee within
30 days after entering into an operation that requires you to register and submit device listing information.)
[ ] NO (If you currently market a medical device and your establishment is required to register and submit device listing information,
FDA will not accept your submission until you have paid all fees due to FDA. See
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/RegistrationandListing/ucm053165.htm for
additional information)
6. IS THIS PREMARKET APPLICATION COVERED BY ANY OF THE FOLLOWING USER FEE EXCEPTIONS? IF SO, CHECK THE APPLICABLE
EXCEPTION.
[ ] This application is the first PMA submitted by a qualified small
[ ] The sole purpose of the application is to support
business, including any affiliates
conditions of use for a pediatric population
[ ] This biologics application is submitted under section 351 of the Public [ ] The application is submitted by a state or federal
Health Service Act for a product licensed for further manufacturing use
government entity for a device that is not to be distributed
only
commercially
7. IS THIS A SUPPLEMENT TO A PREMARKET APPLICATION FOR WHICH FEES WERE WAIVED DUE TO SOLE USE IN A PEDIATRIC
POPULATION THAT NOW PROPOSES CONDITION OF USE FOR ANY ADULT POPULATION? (If so, the application is subject to the fee that
applies for an original premarket approval application (PMA).
[ ] YES
[ ] NO
PAPERWORK REDUCTION ACT STATEMENT
Public reporting burden for this collection of information is estimated to average 18 minutes per response, including the time for
reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the
collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including
suggestions for reducing this burden, to the address below.

  https://userfees.fda.gov/OA_HTML/mdufmaCScdCfgItemsPopup.jsp?ordnum=6097306

6/27/2018

  Site: MDUFMA Cover Sheet
 
 
 
 

Page 2 of 2

 
Department of Health and Human Services, Food and Drug Administration, Office of Chief Information Officer, Paper Reduction Act (PRA)
Staff, [email protected]
[Please do NOT return this form to the above address, except as it pertains to comments on the burden estimate.]
 

8. USER FEE PAYMENT AMOUNT SUBMITTED FOR THIS PREMARKET APPLICATION

 
Form FDA 3601 (08/16)

 

 
"Close Window" Print Cover sheet

  https://userfees.fda.gov/OA_HTML/mdufmaCScdCfgItemsPopup.jsp?ordnum=6097306

6/27/2018


File Typeapplication/pdf
File TitleMicrosoft Word - blank_MDUFA_CS.docx
AuthorSoo.Suh
File Modified2019-07-18
File Created2018-12-18

© 2024 OMB.report | Privacy Policy